McGrew; Jeffrey T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for McGrew; Jeffrey T..The latest application filed is for "inducible expression from transposon-based vectors and uses".
- McGrew; Jeffrey T. - Woodinville WA
- McGrew; Jeffrey T. - Seattle WA
- McGrew; Jeffrey T - Madison CT
- McGrew; Jeffrey T - Seattle WA
- McGrew, Jeffrey T. - Madison CT
| Patent | Date |
|---|---|
| Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors Grant 11,384,140 - Ketchem , et al. July 12, 2 | 2022-07-12 |
| Inducible Expression From Transposon-based Vectors And Uses App 20220177916 - McGrew; Jeffrey T. ; et al. | 2022-06-09 |
| Inducible expression from transposon-based vectors and uses Grant 11,261,462 - McGrew , et al. March 1, 2 | 2022-03-01 |
| Expression from transposon-based vectors and uses Grant 11,098,310 - McGrew , et al. August 24, 2 | 2021-08-24 |
| Expression From Transposon-based Vectors And Uses App 20210189403 - McGrew; Jeffrey T. ; et al. | 2021-06-24 |
| Hybrid promoter and uses thereof Grant 11,028,410 - McGrew , et al. June 8, 2 | 2021-06-08 |
| Inducible Expression From Transposon-based Vectors And Uses App 20190185881 - McGrew; Jeffrey T. ; et al. | 2019-06-20 |
| Expression From Transposon-based Vectors And Uses App 20190185863 - McGrew; Jeffrey T. ; et al. | 2019-06-20 |
| Direct Selection Of Cells Expressing High Levels Of Heteromeric Proteins Using Glutamine Synthetase Intragenic Complementation Vectors App 20190127452 - KETCHEM; Randal Robert ; et al. | 2019-05-02 |
| Hybrid Promoter And Uses Thereof App 20190055580 - McGrew; Jeffrey T. ; et al. | 2019-02-21 |
| Il-18 Receptor Antigen Binding Proteins App 20140093915 - SMITH; DIRK E. ; et al. | 2014-04-03 |
| Methods of treatment using IL-18 receptor antigen binding proteins Grant 8,540,993 - Smith , et al. September 24, 2 | 2013-09-24 |
| Il-18 Receptor Antigen Binding Proteins App 20130034569 - SMITH; Dirk E. ; et al. | 2013-02-07 |
| IL-18 receptor antigen binding proteins Grant 8,257,707 - Smith , et al. September 4, 2 | 2012-09-04 |
| Selection of cells expressing heteromeric polypeptides Grant 7,968,313 - McGrew , et al. June 28, 2 | 2011-06-28 |
| Il-18 Receptor Antigen Binding Proteins App 20110014201 - Smith; Dirk E. ; et al. | 2011-01-20 |
| Selection of cells expressing heteromeric polypeptides Grant 7,691,605 - McGrew , et al. April 6, 2 | 2010-04-06 |
| Selection of Cells Expressing Heteromeric Polypeptides App 20100055794 - McGrew; Jeffrey T. ; et al. | 2010-03-04 |
| Methods for increasing polypeptide production Grant 7,452,695 - Van Ness , et al. November 18, 2 | 2008-11-18 |
| Selection of cells expressing heteromeric polypeptides App 20070031422 - McGrew; Jeffrey T. ; et al. | 2007-02-08 |
| Methods of using mutant flt3-ligand polypeptides to induce cellular expansion Grant 7,067,118 - Graddis , et al. June 27, 2 | 2006-06-27 |
| Cell culture performance with vanadate Grant 6,974,681 - McGrew December 13, 2 | 2005-12-13 |
| Methods for increasing polypeptide production App 20050233415 - Van Ness, Kirk P. ; et al. | 2005-10-20 |
| Methods for increasing polypeptide production Grant 6,872,549 - Van Ness , et al. March 29, 2 | 2005-03-29 |
| Vectors and methods for recombinant protein expression App 20040063186 - McGrew, Jeffrey T. | 2004-04-01 |
| Methods for increasing polypeptide production App 20030211579 - Van Ness, Kirk P. ; et al. | 2003-11-13 |
| Vectors and methods for recombinant protein expression Grant 6,632,637 - McGrew October 14, 2 | 2003-10-14 |
| Selection of cells expressing heteromeric polypeptides App 20030082735 - McGrew, Jeffrey T. ; et al. | 2003-05-01 |
| Flt3-L mutants and methods of use App 20020111475 - Graddis, Thomas J. ; et al. | 2002-08-15 |
| DNA encoding CD40 ligand, a cytokine that binds CD40 Grant 6,410,711 - Armitage , et al. June 25, 2 | 2002-06-25 |
| DNA encoding CD40 ligand, a cytokine that binds CD40 Grant 5,981,724 - Armitage , et al. November 9, 1 | 1999-11-09 |
| Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same Grant 5,962,406 - Armitage , et al. October 5, 1 | 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 